What Happened to HIV/AIDS in Zambia (Post-US Aid Cuts)?

Zambia's journey in combating HIV/AIDS has been significantly shaped by international aid, particularly from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). For years, PEPFAR was a cornerstone of Zambia's HIV response, contributing substantially to its success in expanding antiretroviral therapy (ART) access and reducing new infections. In 2005, PEPFAR funding enabled the elimination of user fees for HIV treatment, a major game-changer. By 2024, Zambia had achieved or exceeded UNAIDS' 95-95-95 targets, with 95% of people living with HIV knowing their status, 94% on ART, and 92% virally suppressed.

However, this progress began to unravel with a shift in U.S. global health policy and subsequent aid reductions. While the U.S. committed $390.5 million for Zambia's HIV response in fiscal year 2023, this figure saw reductions, with $367 million committed for 2025. The underlying reasons for these cuts are multifaceted, including a broader 'America First' transactional approach to foreign assistance, prioritizing bilateral agreements and co-financing, and a desire for greater domestic ownership by recipient countries. Previous issues, such as the theft of donated medicines, also contributed to tensions and earlier aid reductions.

A critical turning point occurred with the "abrupt withdrawal of bilateral aid in January 2025," which triggered widespread disruptions. This led to the termination of key programs, including the closure of 32 wellness centers serving over 20,000 key populations across seven provinces, and the shutdown of DREAMS programs for adolescent girls and young women in 21 districts. More than 11,000 health workers supporting the HIV response were impacted, and critical outreach programs were eliminated. The consequences have been severe: hospitals are reportedly filling with dying patients, and an estimated 100,000 people stopped taking their medication in the upheaval, with 40,000 yet to be re-engaged. Modeling studies projected that unabated disruptions could lead to over 1 million additional adult deaths and nearly a quarter-million child deaths by 2060, with new HIV infections resurging by over 3 million.

As of May 9, 2026, the situation remains critical. Sweeping U.S. cuts to PEPFAR have reportedly triggered a collapse of HIV prevention and treatment services across Zambia. The Zambian government has gone into emergency mode, redeploying staff to keep antiretroviral medication moving. A highly controversial development emerged with reports that the U.S. State Department had tied HIV funding to Zambia granting the United States expanded access to its mineral resources, setting an April 30, 2026 deadline for a new health funding agreement. Zambia has reportedly rejected this "trade for aid" deal, which was valued at $2 billion, further exacerbating the funding crisis. In response, Zambia is actively working on a National AIDS Strategic Framework (NASF) 2023-2027 and a Zambia Sustainability Roadmap: Vision 2030 and Beyond, aiming to increase domestic funding (from 7% in 2022 to 10% in 2024) and reduce reliance on external aid. The country also secured new grants worth US$362 million from the Global Fund for 2024-2026 to support HIV, TB, and malaria efforts. Despite these efforts, the immediate impact of the aid cuts and the unresolved aid-for-minerals dispute pose a significant threat to the gains made in Zambia's HIV response.